Profil
Actuellement, Kimi E. Iguchi occupe le poste de directrice financière et trésorière de SAGE Therapeutics, Inc. Mme Iguchi est également membre du conseil d'administration de Disarm Therapeutics, Inc. Auparavant, elle a été vice-présidente des finances de Cyberkinetics Neurotechnology Systems, Inc. et directrice de l'exploitation pour la région de l'Amérique du Nord de Santhera Pharmaceuticals Holding AG, directrice principale des rapports externes de Biogen, Inc. et directrice des finances de Biogen MA, Inc. (une filiale de Biogen, Inc.), directrice principale des finances, des rapports et de l'analyse chez Millennium Pharmaceuticals, Inc. et directrice de l'assurance commerciale chez PricewaterhouseCoopers LLP. Mme Iguchi a obtenu un diplôme de premier cycle à l'université Drew et un MBA à l'université Northeastern.
Postes actifs de Kimi Iguchi
| Sociétés | Poste | Début |
|---|---|---|
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Directeur/Membre du Conseil | 25/10/2018 |
Anciens postes connus de Kimi Iguchi
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Directeur Financier/CFO | 31/10/2024 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01/09/2011 |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Directeur Financier/CFO | 31/05/2007 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/1998 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 01/01/1995 |
Formation de Kimi Iguchi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Drew University
Drew University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
















